immunotherapy

June 14, 2018
Jyoti Patel, MD, FASCO

What You Need to Know About Lung Cancer

English
jyoti.patel

Lung cancer affects tens of thousands of Americans every year. In this blog post, Cancer.Net Associate Editor Dr. Jyoti Patel describes 9 things every person should know about lung cancer.

Read More >>
2018 ASCO Annual Meeting; #ASCO18
June 3, 2018
Monika Sharda, ASCO staff

ASCO Annual Meeting 2018: Less Treatment Needed for Some Patients With Breast Cancer and Kidney Cancer, Immunotherapy for Non-Small Cell Lung Cancer, and Maintenance Chemotherapy for Rhabdomyosarcoma

English
Monika.Sharda

Oncology professionals from around the globe are at the 2018 ASCO Annual Meeting. Today’s key research highlights include new treatment options and improved survival for breast cancer, kidney cancer, non-small cell lung cancer, and rhabdomyosarcoma.

Read More >>
2018 ASCO Annual Meeting; #ASCO18
June 2, 2018
Greg Guthrie, ASCO staff

ASCO Annual Meeting 2018: New Insight Into Lynch Syndrome, Finding and Treating Lung Cancer, a New Targeted Therapy for Breast Cancer, and Evidence that Personalized Medicine Helps

English
gregguthrie

Oncology professionals from around the globe are at the 2018 ASCO Annual Meeting. Today’s key research highlights address the connection between microsatellite instability and Lynch syndrome, a blood test that may be used to find early lung cancer, a new targeted therapy for treating advanced breast cancer, an immunotherapy-chemotherapy combination that slows lung cancer growth, and evidence that personalized medicine helps people with cancer live longer.

Read More >>
February 14, 2018
Greg Guthrie, ASCO staff

Biosimilars and Cancer Care: An Expert Opinion

English
gregguthrie

In this podcast, Dr. Gary Lyman describes biosimilars for cancer treatment and why they are important. He also talks about why ASCO is releasing a statement on them today.

Read More >>
February 14, 2018
Laura Porter, MD

What You Need to Know About Immunotherapy Side Effects

English
Laura.Porter

ASCO and NCCN have worked together to help clinicians and patients identify and treat the side effects of immunotherapy before they become dangerous. Doctor and patient advocate Laura Porter describes what to watch out for if you’re taking an immune checkpoint inhibitor, a type of immunotherapy, for cancer.

Read More >>
American Society of Clinical Oncology; Clinical Cancer Advances 2018: ASCO's Annual Report on Progress Against Cancer
January 30, 2018
Greg Guthrie, ASCO staff

CAR T-Cell Immunotherapy: The 2018 Advance of the Year

English
gregguthrie

The 2018 Clinical Cancer Advances report of the American Society of Clinical Oncology has crowned an adoptive cell immunotherapy as its Advance of the Year. What is this innovative cancer treatment? What are the risks and benefits?

Read More >>

Pages

Subscribe to RSS - immunotherapy